Allogene Therapeutics, Inc.

NASDAQ:ALLO

Biotechnology

Healthcare
$0.74 +1.02%

+$0.02 today

Market cap
$257.81M
Beta
0.46
P/E (TTM)
-2.7
EPS (TTM)
-$0.72
52W Low $0.98High $4.46

Volume 8.49M

Average 10.19M

Private 5-step workspace

Build a ALLO investment thesis

Turn Allogene Therapeutics, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.